Filtros : "European Journal of Internal Medicine" Limpar

Filtros



Refine with date range


  • Source: European Journal of Internal Medicine. Unidade: ICB

    Subjects: IMUNOLOGIA, AUTOANTICORPOS, APOLIPOPROTEÍNAS, EPITOPOS, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, LIPOPROTEÍNAS LDL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANT´ANNA, Viviane Aparecida Rodrigues et al. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. Disponível em: https://doi.org/10.1016/j.ejim.2023.07.018. Acesso em: 27 abr. 2024. , 2023
    • APA

      Sant´Anna, V. A. R., Izar, M. C. O., Fonseca, H. A. R. da, & Gidlund, M. A. (2023). Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. doi:https://doi.org/10.1016/j.ejim.2023.07.018
    • NLM

      Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018
    • Vancouver

      Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018
  • Source: European Journal of Internal Medicine. Unidade: FSP

    Subjects: SURTOS DE DOENÇAS, VARÍOLA, FATORES DE RISCO, TRANSMISSÃO DE DOENÇAS, PESQUISA QUANTITATIVA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINS-FILHO, Paulo Ricardo e TANAJURA, Diego Moura e VECINA NETO, Gonzalo. Multi-country monkeypox outbreak: A quantitative evidence synthesis on clinical characteristics, potential transmission routes, and risk factors. European Journal of Internal Medicine, v. 107, p. 102-104, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejim.2022.09.013. Acesso em: 27 abr. 2024.
    • APA

      Martins-Filho, P. R., Tanajura, D. M., & Vecina Neto, G. (2022). Multi-country monkeypox outbreak: A quantitative evidence synthesis on clinical characteristics, potential transmission routes, and risk factors. European Journal of Internal Medicine, 107, 102-104. doi:10.1016/j.ejim.2022.09.013
    • NLM

      Martins-Filho PR, Tanajura DM, Vecina Neto G. Multi-country monkeypox outbreak: A quantitative evidence synthesis on clinical characteristics, potential transmission routes, and risk factors [Internet]. European Journal of Internal Medicine. 2022 ;107 102-104.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2022.09.013
    • Vancouver

      Martins-Filho PR, Tanajura DM, Vecina Neto G. Multi-country monkeypox outbreak: A quantitative evidence synthesis on clinical characteristics, potential transmission routes, and risk factors [Internet]. European Journal of Internal Medicine. 2022 ;107 102-104.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2022.09.013
  • Source: European Journal of Internal Medicine. Unidade: FM

    Subjects: ASMA (TERAPIA), FÁRMACOS SINTÉTICOS (APLICAÇÕES TERAPÊUTICAS), CÓRTEX SUPRARRENAL, CO-TERAPIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIAVINA-BIANCHI, Pedro e KALIL, Jorge. Omalizumab administration in Churg–Strauss syndrome [Carta]. European Journal of Internal Medicine. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ejim.2008.12.008. Acesso em: 27 abr. 2024. , 2009
    • APA

      Giavina-Bianchi, P., & Kalil, J. (2009). Omalizumab administration in Churg–Strauss syndrome [Carta]. European Journal of Internal Medicine. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.ejim.2008.12.008
    • NLM

      Giavina-Bianchi P, Kalil J. Omalizumab administration in Churg–Strauss syndrome [Carta] [Internet]. European Journal of Internal Medicine. 2009 ; 20( 6): e139.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2008.12.008
    • Vancouver

      Giavina-Bianchi P, Kalil J. Omalizumab administration in Churg–Strauss syndrome [Carta] [Internet]. European Journal of Internal Medicine. 2009 ; 20( 6): e139.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2008.12.008
  • Source: European Journal of Internal Medicine. Unidade: FM

    Subjects: HEPATITE B, VACINAS VIRAIS, VACINAÇÃO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARVALHO, Jozélio Freire de e PEREIRA, Rosa Maria Rodrigues e SHOENFELD, Yehuda. Systemic polyarteritis nodosa following hepatitis B vaccination. European Journal of Internal Medicine, v. 19, n. 8, p. 575-578, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejim.2007.06.035. Acesso em: 27 abr. 2024.
    • APA

      Carvalho, J. F. de, Pereira, R. M. R., & Shoenfeld, Y. (2008). Systemic polyarteritis nodosa following hepatitis B vaccination. European Journal of Internal Medicine, 19( 8), 575-578. doi:10.1016/j.ejim.2007.06.035
    • NLM

      Carvalho JF de, Pereira RMR, Shoenfeld Y. Systemic polyarteritis nodosa following hepatitis B vaccination [Internet]. European Journal of Internal Medicine. 2008 ; 19( 8): 575-578.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2007.06.035
    • Vancouver

      Carvalho JF de, Pereira RMR, Shoenfeld Y. Systemic polyarteritis nodosa following hepatitis B vaccination [Internet]. European Journal of Internal Medicine. 2008 ; 19( 8): 575-578.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/j.ejim.2007.06.035
  • Source: European Journal of Internal Medicine. Unidade: FM

    Assunto: CARDIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MEDINA, Wilson Luvizotto et al. High-density lipoprotein cholesterol esterification and transfer rates to lighter density liproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus. European Journal of Internal Medicine, v. 11, p. 264-270, 2000Tradução . . Disponível em: https://doi.org/10.1016/s0953-6205(00)00101-1. Acesso em: 27 abr. 2024.
    • APA

      Medina, W. L., Nunes, V. S., Carrilho, A. J. F., Shimabukuro, A. F. M., Lottenberg, A. M. P., Quintão, E. C. da R., et al. (2000). High-density lipoprotein cholesterol esterification and transfer rates to lighter density liproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus. European Journal of Internal Medicine, 11, 264-270. doi:10.1016/s0953-6205(00)00101-1
    • NLM

      Medina WL, Nunes VS, Carrilho AJF, Shimabukuro AFM, Lottenberg AMP, Quintão EC da R, Lottenberg SA, McPherson R, Krauss RM. High-density lipoprotein cholesterol esterification and transfer rates to lighter density liproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus [Internet]. European Journal of Internal Medicine. 2000 ; 11 264-270.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/s0953-6205(00)00101-1
    • Vancouver

      Medina WL, Nunes VS, Carrilho AJF, Shimabukuro AFM, Lottenberg AMP, Quintão EC da R, Lottenberg SA, McPherson R, Krauss RM. High-density lipoprotein cholesterol esterification and transfer rates to lighter density liproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus [Internet]. European Journal of Internal Medicine. 2000 ; 11 264-270.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/s0953-6205(00)00101-1

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024